Literature DB >> 16084284

Kidney disease and cardiovascular disease: implications of dyslipidemia.

William F Keane1, Paulette A Lyle.   

Abstract

Cardiovascular complications are common inpatients with kidney disease. Regulating the lipid levels in these patients is important so that the risks of kidney and cardiovascular complications can be minimized. Lipid regulation decreases the incidence of coronary vascular events and other vascular complications in patients with kidney disease; however, whether lipid regulation slows progression of kidney disease is not yet known. Additional studies of the implications of dyslipidemia in patients with kidney disease are needed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084284     DOI: 10.1016/j.ccl.2005.03.004

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  5 in total

Review 1.  Kidney aging--inevitable or preventable?

Authors:  Devasmita Choudhury; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2011-08-09       Impact factor: 28.314

2.  HDL and Kidney Diseases.

Authors:  Huanhuan Cao; Xia Meng
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  Multiple indications for anti-inflammatory apolipoprotein mimetic peptides.

Authors:  Brian J Van Lenten; Mohamad Navab; G M Anantharamaiah; Georgette M Buga; Srinivasa T Reddy; Alan M Fogelman
Journal:  Curr Opin Investig Drugs       Date:  2008-11

4.  Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats.

Authors:  Qi Zhang; Guang-ji Wang; Ji-ye A; Di Wu; Ling-ling Zhu; Bo Ma; Yu Du
Journal:  Acta Pharmacol Sin       Date:  2009-12       Impact factor: 6.150

5.  What's the Optimal Lipids Level for Dialysis Patients? A Cohort Study from a Chinese Dialysis Center in a University Hospital.

Authors:  Wen-Ling Yang; Xue-Yan Zhu; Ning Zhu; Chun-Yan Su; Qing-Feng Han; Tao Wang; Ai-Hua Zhang
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.